Task: Answer the multiple-choice question.
Query: Which compound exhibits a -1.725% hERG inhibition at a concentration of 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
a.) CCCn1c(SCC(=O)c2ccc3c(c2)OCCO3)nnc1-c1ccco1
b.) CCOc1ccc(NC(=O)C2CCN(S(=O)(=O)c3cccnc3)CC2)cc1
c.) Cc1cccc2cc(/C=N/NC(=O)CN3CCOCC3)c(Cl)nc12
Answer: c. Cc1cccc2cc(/C=N/NC(=O)CN3CCOCC3)c(Cl)nc12
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1cccc2cc(/C=N/NC(=O)CN3CCOCC3)c(Cl)nc12
Cc1cccc2cc(/C=N/NC(=O)CN3CCOCC3)c(Cl)nc12
N-[(E)-(2-chloro-8-methylquinolin-3-yl)methylideneamino]-2-morpholin-4-ylacetamide